European Psychiatry - Volume 41 - April 2017

255 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S238–S302 S251
EW0424
Study on female refugees – A
representative research study on
refugee women in Germany
E. Sönmez ∗, J. Jesuthasan , I. Abels , R. Nassar , C. Kurmeyer ,
M. Schouler-Ocak
1 Marmara University Pendik Training and Research Hospital,
Psychiatry, Istanbul, Turkey
2 Psychiatrische Universitätsklinik der Charité Campus Mitte im St.
Hedwig Krankenhaus, Psychiatry, Berlin, Germany
3 Charité Universitätsmedizin Berlin, Mentoring Competence Centers,
Berlin, Germany
4 Charité Universitätsmedizin Berlin, Zentrale Frauen- und
Gleichstellungsbeauftragte, Berlin, Germany
∗ Corresponding author.
Introduction Germany is one of the European countries that
receive the highest number of refugees for the last years, with
around 468 thousand asylum seekers in the first half of 2016. How-
ever, the increase in the speed of short-term procedures regarding
refugees may at the same time overlook the risks regarding specific
populations. Moreover, women and children constitute the most
vulnerable groups during war and conflicts and the worst effects,
in terms of physical, mental and social consequences, develop on
these groups.
Objectives To understand deeply the psychosocial situation of
female refugees that have arrived in Federal German Republic, to
assess their challenges and resources before, during and after the
displacement and to propose recommendations for policy changes.
Methods The study consists of two modules, taking place in five
states in Federal German Republic, including Berlin, Mecklenburg-
Vorpommern, Bayern, Hessen und Mainz. In the first step, a
representative stratified sample of female refugees fromSyria, Iraq,
Iran, Afghanistan, Somali and Eritrea are recruited. The quantita-
tive study instrument include a socio-demographic question form
and HSCL-Hopkins checklist, Harvard Trauma questionnaire, Beck
depressions inventory, EUROHIS–QOL and SCL-14. In the second
step, a qualitative in-depth analysis of focus group meetings is
conducted.
Results and conclusions There is an urgent need to take action for
the mental health problems of refugees. This study constitutes one
of the most extensive researches, especially on a subpopulation of
refugees that requires specific attention. Challenges faced through-
out the protocol and detailed results will be shared as presentation.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
e-Poster Walk: Oncology and Psychiatry and Pain
and Treatment Options
EW0425
Pharmacological issues in cancer
patients
M. Alves ∗, A. Tavares
1 Hospital de Magalhães Lemos, Servic¸ o C, Porto, Portugal
2 Instituto Portugês de Oncologia do Porto, Servic¸ o de
Psico-Oncologia, Porto, Portugal
∗ Corresponding author.
Introduction Depression and anxiety are the main causes of psy-
chiatric disorder in cancer patients, associated with a decreased
tolerance and adherence to cancer treatment, longer hospital stays,
decreased quality of life and possibly influence prognosis and mor-
tality.
Objectives This review will address psychopharmacological
options in cancer patients, side effects and possible drug inter-
actions between psychotropic drugs and chemotherapy, either by
toxicity, to which these patients are more sensitive, or a reduction
in efficacy in anti-tumor treatment.
Methods Non systematic literature review through the Medline
and clinical key databases, with time constraints.
Results Selective Serotonin Reuptake Inhibitors are the first line
treatment for depression, because of their tolerability and safety
profile. Venlafaxine is the safer choice for the treatment of depres-
sion and hot flushes in women with breast cancer undergoing
chemotherapy with tamoxifen. Tricyclic antidepressants are used
in patients with neuropathic pain, due to its analgesic properties.
Haloperidol is the safest antipsychotic, with less drug interactions
and lower metabolic risk. Benzodiazepines are used in anxiety
states for short periods. Psychostimulants are an option in patients
with depression and life expectancy of less than one month. Mood
stabilizers are recommended to treat mania, commonly induced by
corticosteroids.
Conclusions Treatment of psychiatric disease in cancer patients
leads to an increased adherence to anti-tumoral treatment and
improves quality of life. Regardless of the cancer stage there is
indication to start treatment. We must, however, take into account
possible side effects and drug interactions between psychotropic
drugs and chemotherapy, through toxicity or diminished efficacy,
when combined with anti-tumoral treatment.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0426
Cancer survivor – What comes next?
M. Alves ∗ avares
1 Hospital de Magalhães Lemos, Servic¸ o C, Porto, Portugal
2 Instituto Português de Oncologia do Porto, Servic¸ o de
Psico-Oncologia, Porto, Portugal
∗ Corresponding author.
Introduction The number of long term cancer survivors (more
than 5 years after diagnosis) are nowadays increasing because of
advances in cancer screening, early detection, treatment strategies
and management of acute treatment toxicities.
Objectives We aim to highlight the long-term psychological
responses or late effect of cancer diagnosis and treatment.
Methods Non systematic literature review through the Medline
and clinical key databases, with time constraints.
Results There are physical and functional difficulties that may
not be solved with the conclusion of treatment or can become
problematic in survivors of cancer.
Long-term refers to psychological or emotional responses that
emerge after cancer diagnosis and treatment and persist for at least
5 years. Late effects of cancer refer to psychological or emotional
responses that emerge after treatment completion. Risk factors to
its development depends on the diagnosis, type of treatment, age
at treatment, time since treatment, genetic vulnerability, psycho-
logical, social and environmental factors.
Specific deficits are more prevalent in survivors than in healthy
adults of the same age. Fatigue, sexual dysfunction, cogni-
tive impairment and musculoskeletal symptoms are common.
Functional limitations that induce restricted physical and social
activities may happen in survivors. Physical function and late
complications can be influenced by lifestyle, socio-economic and
biologic factors.
Conclusions Cancer survivors face short-term and long-term
challenges to physical and mental health and they need to be
addressed in the active treatment and throughout the continuum